Showing results (191-200 of 212) with videos related to
Sort By:
Pageof 22
Journal of Ethnopharmacology|September 19, 2006
Hypoglycemic, vasorelaxant and hepatoprotective effects of Cochlospermum vitifolium (Willd.) Sprengel: a potential agent for the treatment of metabolic syndromeJ C Sánchez-Salgado, R R Ortiz-Andrade, F Aguirre-Crespo, et al.British Journal of Pharmacology|February 5, 2013
Different β-adrenoceptor subtypes coupling to cAMP or NO/cGMP pathways: implications in the relaxant response of rat conductance and resistance vesselsN Flacco, V Segura, M Perez-Aso, et al.International Journal of Immunopharmacology|December 5, 1998
Comparative study of transfer factor and acyclovir in the treatment of herpes zosterS Estrada-Parra, A Nagaya, E Serrano, et al.Archivos Del Instituto De Cardiologia De Mexico|January 1, 1994
[Intraoperative circulatory collapse due to a coronary spasm following successful coronary revascularization]M S Urrea Ramos, S Celaya Lara, J A Santibáñez Salgado, et al.Scandinavian Journal of Immunology|April 20, 2001
Connectivity patterns in tuberculosis and leprosy patients are indistinguishable from that of healthy donorsT Tovar-Rivera, S Sánchez-Colón, L Padierna-Olivos, et al.Clinical and Experimental Immunology|June 4, 2005
Differential pattern of cytokine expression by macrophages infected in vitro with different Mycobacterium tuberculosis genotypesR Chacón-Salinas, J Serafín-López, R Ramos-Payán, et al.The Journal of Parasitology|June 19, 2010
Seroepidemiology of Toxoplasma gondii infection in patients with vision and hearing impairments, cancer, HIV, or undergoing hemodialysis in Durango, MexicoC Alvarado-Esquivel, O Liesenfeld, A Torres-Castorena, et al.Clinical & Developmental Immunology|October 10, 2013
Low-dose amphotericin B and murine dialyzable spleen extracts protect against systemic candida infection in miceF Robledo-Ávila, M Pérez-Tapia, A Limón-Flores, et al.Proceedings of the National Academy of Sciences of the United States of America|January 3, 1995
Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3'-azido-3'-deoxythymidine-resistant HIV-1 strainsD L Mayers, J A Mikovits, B Joshi, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 22, 2020
18F-Radiolabeling and Preliminary Evaluation of a HSP90 ligandP Nordeman, Z P Jayendra, E Briard, et al.Pageof 22